Transchem Ltd.
Snapshot View

View in App

Prices View details

28.40 +1.25 ▲4.6%

26 July 2021, 04:00:00 P.M.
Volume: 5,535

Overview View Details

Sector Agriculture Compare with Sector peers
Industry Agriculture Compare with Industry peers
Website http://www.transpharma.com
Financial Indicators
Market Cap 34.76 Cr.
Earnings per share (EPS) 19.73 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 1.44 Trailing Twelve Months Ending 2021-03
Industry PE 18.65 Trailing Twelve Months Ending 2021-03
Book Value / Share 51.42 Trailing Twelve Months Ending 2021-03
Price to Book Value 0.55 Calculated using Price: 28.40
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 1.22 Cr. 12,240,000 Shares
FaceValue 10
Company Profile

Transchem limited is a professionally managed, public limited company, the API manufacturing operations were started in 1993. The company is reputed as quality conscious manufacturer and exporter of specialized high quality API's and pharmaceutical intermediates.

The company is the largest producer of widest range of Anathematic API's (Anti-Parasitic) in the world, manufactured under one roof in WHO GMP accredited facility. It also offers specialized range of human use API’s.

The company is having four state of the art GMP approved facilities at multiple locations in India, with total production capacity of 500 MT per annum.

The company is one of the largest suppliers of Albendazole, Clorsulon, Diminazene Diaceturate, Toldimfos Sodium, Oxfendazole, Fenbendazole, Flubendazole, Mebendazole, Nitroxynil, Ramipril from India and can meet all the requiered technical and quality aspects of esteemed organizations and is now focusing on Anti-Hypertensive and Anti-Diabetic range of products.

Products and services offered by the company:

Services:

  • Contract Research Facility.
  • Custom Synthesis of Molecules.
  • Contract Manufacturing of API's as per GMP Guidelines.
  • Intermediates.
  • Veterinary Formulations.
  • Q.A. & Regulatory Support.

Product:

Anthelmintics

  • Albendazole USP / EP /BP
  • Ricobendazole (Albendazole Sulphoxide)
  • Mebendazole EP / BP / USP / POLY 'C'
  • Oxyclozanide BP VET
  • Closantel Sodium EP / BASE
  • Clorsulon USP
  • Nitroscanate
  • Fenbendazole EP/BP/BP VET
  • Oxfendazole BP VET / EP
  • Flubendazole EP / 98%
  • Nitroxynil BP VET
  • Rafoxanide BP VET
  • Triclabendazole
  • Praziquantel BP / USP

Veterinary API's

  • Diminazene Diaceturate B VET C
  • Quinapyramine Salts B VET C
  • Parvaquone
  • Toldimfos Sodium
  • Acepromazine Maleate BP VET
  • Butaphosphan
  • Flunixin Meglumine USP
  • Homidium Bromide / Chloride
  • Isometamedium

Ectoparaciticides

  • Cyromazine.
  • Cymiazole
  • S-Methoprene
  • Azamethiphos.

Human Use API's

  • Ramipril EP
  • Frusemide EP / BP / USP
  • Gabapentin USP
  • Cetirizine DI HCL EP/BP
  • Lamotrigine
  • Pentamidine Isetionate BP
  • Succinylcholine Chloride USP
  • Epinastine HCL
  • Nifuroxazide

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+4.60%
1 Week
-0.35%
1 Month
+7.98%
3 Month
+25.39%
6 Month
+49.47%
1 Year
+170.48%
2 Year
+71.60%
5 Year
+56.04%

Ratios View Details

9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) -7.94 -3.32 -2.08 0.31 0.12 -0.57 -3.18 0.82 1.10
Return on Capital Employed (%) -8.04 -2.51 -1.85 0.31 0.12 -0.57 -1.47 2.07 2.12
Return on Assets (%) -7.34 -3.13 -2.05 0.31 0.12 -0.58 -3.19 0.81 1.09

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 40 39 38 38 38 38 37 38 37
Non Curr. Liab. 2 1 0 0 0 -1 0 0 0
Curr. Liab. 1 0 0 0 0 0 0 0 0
Minority Int.
Equity & Liab. 44 41 38 38 38 38 37 38 37
Non Curr. Assets 15 13 12 11 10 8 7 10 7
Curr. Assets 29 27 26 27 28 29 30 28 30
Misc. Exp. not W/O
Total Assets 44 41 38 38 38 38 37 38 37

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales
Other Income 2 2 2 2 2 2 2 3 3
Total Income 2 2 2 2 2 2 2 3 3
Total Expenditure -4 -2 -1 -1 -1 -1 -2 -1 -1
PBIDT -2 1 1 1 1 1 0 2 1
Interest 0 0 0
Depreciation -2 -2 -2 -1 -1 -1 -1 -1 -1
Taxation 0 0 -1 0 0
Exceptional Items 0 0 0
PAT -3 -1 -1 0 0 0 -1 0 0

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 1 2 1 1 1 1 -20 10 -1
Cash Fr. Inv. -2 0 1 -1 0 -2 20 6 1
Cash Fr. Finan. -1 -2
Net Change -1 0 0 0 1 -1 0 16 0
Cash & Cash Eqvt 0 1 1 0 1 0 0 16 16

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 34.92 34.92 34.92 34.92 34.92 39.29 39.29 39.86 39.86
Public 65.08 65.08 65.08 65.08 65.08 60.71 60.71 60.14 60.14
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Wed, 07 Jul 2021
Shareholding for the Period Ended June 30 2021
Transchem Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here
Wed, 07 Jul 2021
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Company is submitting copy of the certificate dated July 01 2021 as received from M/s. Adroit Corporate Services Private Limited Registrar and Share Transfer Agent (RTA) as per Regulation 74 (5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2021
Wed, 07 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- Neeraja Karandikar
Designation :- Company Secretary and Compliance Officer

Technical Scans View Details

Mon, 26 Jul 2021
Both SRS And ARS Above Zero Both SRS And ARS Above Zero
ATR Increasing for 3 Days ATR Increasing for 3 Days
Stochastic %K Crossing %D from Below Stochastic %K Crossing %D from Below
Stochastic In Oversold Zone Stochastic In Oversold Zone
Fri, 23 Jul 2021
Both SRS And ARS Above Zero Both SRS And ARS Above Zero

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Tata Consumer Products Ltd. 71,544.67 776.35 +0.2%
Bombay Burmah Trading Corporation Ltd. 8,759.51 1,255.45 -1.3%
E.I.D. - Parry (India) Ltd. 7,540.13 425.75 +3.2%
Shree Renuka Sugars Ltd. 7,460.36 35.05 +4.9%
Balrampur Chini Mills Ltd. 7,138.95 340.05 -0.9%
CCL Products (India) Ltd. 5,519.33 414.90 -1.6%
Venky'S (India) Ltd. 4,452.37 3,162.70 +3.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2021-03 83.51 776.35 +0.2%
Bombay Burmah Trading Corporation Ltd. Consolidated 2021-03 23.70 1,255.45 -1.3%
E.I.D. - Parry (India) Ltd. Consolidated 2021-03 16.85 425.75 +3.2%
Shree Renuka Sugars Ltd. Consolidated 2021-03 0.00 35.05 +4.9%
Balrampur Chini Mills Ltd. Consolidated 2021-03 14.88 340.05 -0.9%
CCL Products (India) Ltd. Consolidated 2021-03 30.28 414.90 -1.6%
Venky'S (India) Ltd. Standalone 2021-03 16.63 3,162.70 +3.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2021-03 4.93 776.35 +0.2%
Bombay Burmah Trading Corporation Ltd. Consolidated 2021-03 1.60 1,255.45 -1.3%
E.I.D. - Parry (India) Ltd. Consolidated 2021-03 1.65 425.75 +3.2%
Shree Renuka Sugars Ltd. Consolidated 2021-03 -3.61 35.05 +4.9%
Balrampur Chini Mills Ltd. Consolidated 2021-03 2.73 340.05 -0.9%
CCL Products (India) Ltd. Consolidated 2021-03 5.08 414.90 -1.6%
Venky'S (India) Ltd. Standalone 2021-03 4.03 3,162.70 +3.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Tata Consumer Products Ltd. Consolidated 2021-03 0.08 776.35 +0.2%
Bombay Burmah Trading Corporation Ltd. Consolidated 2020-03 0.40 1,255.45 -1.3%
E.I.D. - Parry (India) Ltd. Consolidated 2020-03 1.11 425.75 +3.2%
Shree Renuka Sugars Ltd. Consolidated 2020-03 -1.23 35.05 +4.9%
Balrampur Chini Mills Ltd. Consolidated 2020-03 0.61 340.05 -0.9%
CCL Products (India) Ltd. Consolidated 2020-03 0.51 414.90 -1.6%
Venky'S (India) Ltd. Standalone 2021-03 0.16 3,162.70 +3.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2021-03 7.02 776.35 +0.2%
Bombay Burmah Trading Corporation Ltd. Consolidated 2020-03 24.20 1,255.45 -1.3%
E.I.D. - Parry (India) Ltd. Consolidated 2020-03 26.91 425.75 +3.2%
Shree Renuka Sugars Ltd. Consolidated 2020-03 0.00 35.05 +4.9%
Balrampur Chini Mills Ltd. Consolidated 2020-03 22.57 340.05 -0.9%
CCL Products (India) Ltd. Consolidated 2020-03 18.78 414.90 -1.6%
Venky'S (India) Ltd. Standalone 2021-03 27.59 3,162.70 +3.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2021-03 8.97 776.35 +0.2%
Bombay Burmah Trading Corporation Ltd. Consolidated 2020-03 29.70 1,255.45 -1.3%
E.I.D. - Parry (India) Ltd. Consolidated 2020-03 21.69 425.75 +3.2%
Shree Renuka Sugars Ltd. Consolidated 2020-03 323.76 35.05 +4.9%
Balrampur Chini Mills Ltd. Consolidated 2020-03 16.11 340.05 -0.9%
CCL Products (India) Ltd. Consolidated 2020-03 18.34 414.90 -1.6%
Venky'S (India) Ltd. Standalone 2021-03 32.10 3,162.70 +3.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2021-03 11,602.03 776.35 +0.2%
Bombay Burmah Trading Corporation Ltd. Consolidated 2020-03 11,890.47 1,255.45 -1.3%
E.I.D. - Parry (India) Ltd. Consolidated 2020-03 17,128.92 425.75 +3.2%
Shree Renuka Sugars Ltd. Consolidated 2020-03 5,487.14 35.05 +4.9%
Balrampur Chini Mills Ltd. Consolidated 2020-03 4,741.29 340.05 -0.9%
CCL Products (India) Ltd. Consolidated 2020-03 1,139.15 414.90 -1.6%
Venky'S (India) Ltd. Standalone 2021-03 3,116.63 3,162.70 +3.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Tata Consumer Products Ltd. Consolidated 2021-03 993.79 776.35 +0.2%
Bombay Burmah Trading Corporation Ltd. Consolidated 2020-03 1,147.51 1,255.45 -1.3%
E.I.D. - Parry (India) Ltd. Consolidated 2020-03 891.21 425.75 +3.2%
Shree Renuka Sugars Ltd. Consolidated 2020-03 1,949.76 35.05 +4.9%
Balrampur Chini Mills Ltd. Consolidated 2020-03 511.55 340.05 -0.9%
CCL Products (India) Ltd. Consolidated 2020-03 165.94 414.90 -1.6%
Venky'S (India) Ltd. Standalone 2021-03 267.74 3,162.70 +3.2%